SIMPSON JENNIFER K. (President and CEO) purchased 129.8% of their position (4.44K shares) of PANBELA THERAPEUTICS, INC. on the open market
Open‑market purchases signal personal conviction — classified as a major conviction buy.
P · 1 purchase
Filed: 2/1/2023ACC: 0001437749-23-002264
DirectorOfficer· President and CEO
Since Jul 2020
+13.33K
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
13.33K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.44K
Price / share
—
Trade value
—
% of position
129.8%
1/30/2023
3.42K→7.87K
Total
Net shares
+4.44K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/30/2023 | P · Purchase | +4.44K | — | — | 129.8% | 3.42K | 7.87K |
| Total | +4.44K | $0.00 | ||||||
Derivative Transactions1
Warrants (right to buy)
Direct
Converts to
Common Stock
8.89K shares
Shares
+8.89K
Strike price
2.75
Held after
8.89K
Exercisable
—
1/30/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants (right to buy) Direct | Common Stock8.89K shares | 1/30/2023 | P · Purchase | +8.89K | 2.75 | — | 8.89K |